{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:56Z","timestamp":1793640716650,"version":"4.5.1"},"reference-count":27,"publisher":null,"issue":"4","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim<\/jats:italic>\n                    To evaluate frequency of administration of anticoagulant therapy (ACT) for atrial fibrillation and to study the effect of chronic antithrombotic therapy (ATT) on kidney function.\n                    <jats:italic>Material and methods<\/jats:italic>\n                    Due to a high medical and social significance of AF, much attention is presently paid to appropriate administration of ACT for AF in clinical practice. The study retrospectively analyzed 776 case reports of hospitalized patients with AF. The effect of chronic ATT on kidney function was studied in 70 patients who were rehospitalized, including 25 patients treated with warfarin, 25 patients treated with direct oral anticoagulants (DOAC), and 20 patients treated with acetylsalicylic acid (ASA).\n                    <jats:italic>Results<\/jats:italic>\n                    In January 2014, at the prehospital stage, 74.3\u200a% of patients did not receive ATT, 14.7\u200a% of patients received antiplatelet therapy, and only 11\u200a% received anticoagulants. In the hospital in January 2014, ACTs were administered to 74.3\u200a% of patients (warfarin, 58.6\u200a%; DOAC, 15.7\u200a%), 20.6\u200a% of patients received antiplatelet drugs, and 5.1\u200a% of patients were discharged without ATT. In January 2019, the number of patients receiving ACT at the prehospital stage increased to 58.1\u200a% (warfarin, 13.8\u200a%; DOAC, 44.3\u200a%); 12\u200a% of patients received antiplatelet drugs; and 29.9\u200a% of patients did not receive ATT. The number of patients treated with warfarin and DOAC in the hospital increased to 14.8\u200a% and 70.6\u200a% (rivaroxaban, 33.4\u200a%; apixaban, 25.5\u200a%, and dabigatran, 11.7\u200a%), respectively. The number of patients taking antiplatelet drugs decreased to 3.7\u200a%, and the number of patients without ATT decreased to 10.9\u200a%. There were no statistically significant differences in glomerular filtration rate (GFR) between these three groups at baseline. Only in the warfarin treatment group, GFR was significantly decreased from baseline during the follow-up period. Comparison of GFR in three study groups at the finale stage of the study showed significant differences between mean GFRs in the warfarin treatment group and the DOAC treatment group and between the warfarin treatment group and the ASA treatment group.\n                    <jats:italic>Conclusion<\/jats:italic>\n                    Among the prescribed and taken anticoagulants, DOACs are presently in the first place. Among DOACs, the most frequently prescribed drug is rivaroxaban. GFR decreases with the DOAC treatment slower than with the warfarin treatment. Despite the slower decrease in GFR with the ASA treatment compared to warfarin, ASA is not indicated for prevention of stroke in AF due to its low efficacy.\n                  <\/jats:p>","DOI":"10.18087\/cardio.2020.4.n1023","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T05:14:45Z","timestamp":1589260485000},"page":"54-61","source":"Crossref","is-referenced-by-count":4,"title":["Stroke Prevention in Patients with Atrial Fibrillation in Real Clinical Practice, Emphasis on Efficacy and Safety of Anticoagulant Therapy"],"prefix":"10.68900","volume":"60","author":[{"given":"T. N.","family":"Novikova","sequence":"first","affiliation":[{"name":"Federal State Budget Educational Institution of Higher Education \"North-Western State Medical University named after I. I. Mechnikov\" of the Ministry of Health of the Russian Federation. Saint-Petersburg State Budget Health Institution \"Pokrovskaya Municipal Hospital\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Ashurov","sequence":"additional","affiliation":[{"name":"Federal State Budget Educational Institution of Higher Education \"North-Western State Medical University named after I. I. Mechnikov\" of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Kiseleva","sequence":"additional","affiliation":[{"name":"Saint-Petersburg State Budget Health Institution \"Pokrovskaya Municipal Hospital\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. O.","family":"Plotnikova","sequence":"additional","affiliation":[{"name":"St. Petersburg State Budget Health Institution \"Municipal Polyclinic No. 96\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Podoprigora","sequence":"additional","affiliation":[{"name":"Federal State Budget Educational Institution of Higher Education \"North-Western State Medical University named after I. I. Mechnikov\" of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Sayganov","sequence":"additional","affiliation":[{"name":"Federal State Budget Educational Institution of Higher Education \"North-Western State Medical University named after I. I. Mechnikov\" of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Khagush","sequence":"additional","affiliation":[{"name":"Federal State Budget Educational Institution of Higher Education \"North-Western State Medical University named after I. I. Mechnikov\" of the Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"ref1","unstructured":"Belenkov Y. N., Shakaryants G. A., Khabarova N. V., An G. V. Anticoagulant Therapy in Elderly Patients With Atrial Fibrillation. Kardiologiia. 2018; 58 (10): 44\u201351. DOI: 10.18087\/cardio.2018.10.10177. Russian (\u0411\u0435\u043b\u0435\u043d\u043a\u043e\u0432 \u042e. \u041d., \u0428\u0430\u043a\u0430\u0440\u044c\u044f\u043d\u0446 \u0413. \u0410., \u0425\u0430\u0431\u0430\u0440\u043e\u0432\u0430 \u041d. \u0412., \u0410\u043d \u0413. \u0412. \u0410\u043d\u0442\u0438\u043a\u043e\u0430\u0433\u0443\u043b\u044f\u043d\u0442\u043d\u0430\u044f \u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0443 \u043f\u043e\u0436\u0438\u043b\u044b\u0445 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0444\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u0435\u0439 \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439. \u041a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u044f. 2018; 58 (10): 44\u201351. DOI: 10.18087\/cardio.2018.10.10177)."},{"key":"ref2","unstructured":"Panchenko E. P., Accetta G., Libis P. A., Miller O. N., Novikova T. N., Nagibovich O. A. Characteristics of Risk Factors and Prescribed Antithrombotic Therapy in Patients With Recent non-Valvular Atrial Fibrillation in the Russian Federation (According to the Results of the International Register GARFIELD-AF) Kardiologiia. 2017; 4: 129\u2013135. DOI: 10.18565\/cardio.2017.4.38-44. Russian (\u041f\u0430\u043d\u0447\u0435\u043d\u043a\u043e \u0415. \u041f., \u0410\u043a\u0441\u0435\u0442\u0430 \u0413., \u041b\u0438\u0431\u0438\u0441 \u0420. \u0410., \u041c\u0438\u043b\u043b\u0435\u0440 \u041e. \u041d., \u041d\u043e\u0432\u0438\u043a\u043e\u0432\u0430 \u0422. \u041d., \u041d\u0430\u0433\u0438\u0431\u043e\u0432\u0438\u0447 \u041e. \u0410. \u0425\u0430\u0440\u0430\u043a\u0442\u0435\u0440\u0438\u0441\u0442\u0438\u043a\u0430 \u0444\u0430\u043a\u0442\u043e\u0440\u043e\u0432 \u0440\u0438\u0441\u043a\u0430 \u0438 \u043d\u0430\u0437\u043d\u0430\u0447\u0430\u0435\u043c\u043e\u0439 \u0430\u043d\u0442\u0438\u0442\u0440\u043e\u043c\u0431\u043e\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u043d\u0435\u0434\u0430\u0432\u043d\u043e \u0432\u043e\u0437\u043d\u0438\u043a\u0448\u0435\u0439 \u043d\u0435\u043a\u043b\u0430\u043f\u0430\u043d\u043d\u043e\u0439 \u0444\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u0435\u0439 \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439 \u0432 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u0438 (\u043f\u043e \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u0430\u043c \u043c\u0435\u0436\u0434\u0443\u043d\u0430\u0440\u043e\u0434\u043d\u043e\u0433\u043e \u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0430 GARFIELD-AF). \u041a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u044f. 2017; 4: 129\u2013135. DOI: 10.18565\/cardio.2017.4.38-44)."},{"key":"ref3","unstructured":"Radha B., Sayganov S. A., Gromyko T. Y. Atrial fibrillation in patients with inferior myocardial infarction. Herald of the Northwestern State Medical University named after I. I. Mechnikov. 2015; 7 (1): 46\u201352. ISSN 2618-9704. DOI: 10.17816\/mechnikov20157146-52. Russian (\u0420\u0430\u0434\u0445\u0430 \u0411., \u0421\u0430\u0439\u0433\u0430\u043d\u043e\u0432 \u0421. \u0410., \u0413\u0440\u043e\u043c\u044b\u043a\u043e \u0422. \u042e. \u0424\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u044f \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0441 \u0438\u043d\u0444\u0430\u0440\u043a\u0442\u043e\u043c \u043c\u0438\u043e\u043a\u0430\u0440\u0434\u0430 \u043d\u0438\u0436\u043d\u0435\u0439 \u043b\u043e\u043a\u0430\u043b\u0438\u0437\u0430\u0446\u0438\u0438. \u0412\u0435\u0441\u0442\u043d\u0438\u043a \u0421\u0435\u0432\u0435\u0440\u043e-\u0417\u0430\u043f\u0430\u0434\u043d\u043e\u0433\u043e \u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442\u0430 \u0438\u043c. \u0418. \u0418. \u041c\u0435\u0447\u043d\u0438\u043a\u043e\u0432\u0430. 2015; 7 (1): 46\u201352. ISSN 2618-9704. DOI: 10.17816\/mechnikov20157146-52)."},{"key":"ref4","unstructured":"Stepina E. V., Loukianov M. M., Bichurina M.A., Belova \u0415. A., Kudryashov E. V., Yuzkov Y. V. et al. Oral Anticoagulants in Ambulatory and In-Hospital Treatment of Patients with Atrial Fibrillation Associated with Hypertension, Ischemic Heart Disease and Chronic Heart Failure: Data from Hospital Registry RECVASA-CLINIC. Ration Pharmacother Cardiol. 2017; 13 (2): 146\u2013154. DOI: 10.20996\/1819-6446-2017-13-2-146-154. Russian. (\u0421\u0442\u0435\u043f\u0438\u043d\u0430 \u0415. \u0412., \u041b\u0443\u043a\u044c\u044f\u043d\u043e\u0432 \u041c. \u041c., \u0411\u0438\u0447\u0443\u0440\u0438\u043d\u0430 \u041c. \u0410., \u0411\u0435\u043b\u043e\u0432\u0430 \u0415. \u0410., \u041a\u0443\u0434\u0440\u044f\u0448\u043e\u0432 \u0415. \u0412., \u042e\u0437\u044c\u043a\u043e\u0432 \u042e. \u0412. \u0438 \u0434\u0440. \u0422\u0435\u0440\u0430\u043f\u0438\u044f \u043e\u0440\u0430\u043b\u044c\u043d\u044b\u043c\u0438 \u0430\u043d\u0442\u0438\u043a\u043e\u0430\u0433\u0443\u043b\u044f\u043d\u0442\u0430\u043c\u0438 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0441 \u0444\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u0435\u0439 \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439 \u0432 \u0441\u043e\u0447\u0435\u0442\u0430\u043d\u0438\u0438 \u0441 \u0430\u0440\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u043e\u0439 \u0433\u0438\u043f\u0435\u0440\u0442\u043e\u043d\u0438\u0435\u0439, \u0438\u0448\u0435\u043c\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u044c\u044e \u0441\u0435\u0440\u0434\u0446\u0430, \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e\u0439 \u043d\u0435\u0434\u043e\u0441\u0442\u0430\u0442\u043e\u0447\u043d\u043e\u0441\u0442\u044c\u044e \u043d\u0430 \u0433\u043e\u0441\u043f\u0438\u0442\u0430\u043b\u044c\u043d\u043e\u043c \u0438 \u0430\u043c\u0431\u0443\u043b\u0430\u0442\u043e\u0440\u043d\u043e\u043c \u044d\u0442\u0430\u043f\u0430\u0445 \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u043f\u043e \u0434\u0430\u043d\u043d\u044b\u043c \u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0430 \u0420\u0415\u041a\u0412\u0410\u0417\u0410-\u041a\u041b\u0418\u041d\u0418\u041a\u0410. \u0420\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u0430\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0432 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438. 2017; 13 (2): 146\u2013154. DOI: 10.20996\/1819-6446-2017-13-2-146-154)."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37 (38): 2893\u20132962. DOI: 10.1093\/ejcts\/ezw313.","DOI":"10.1093\/ejcts\/ezw313"},{"key":"ref6","unstructured":"Novikova T. N. Stroke prevention in non-valvular form of atrial fibrillation. Translational medicine. 2014; 2: 5\u201312. ISSN 2311-4495. Russian (\u041d\u043e\u0432\u0438\u043a\u043e\u0432\u0430 \u0422. \u041d. \u041f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0430 \u0438\u043d\u0441\u0443\u043b\u044c\u0442\u0430 \u043f\u0440\u0438 \u043d\u0435\u043a\u043b\u0430\u043f\u0430\u043d\u043d\u043e\u0439 \u0444\u043e\u0440\u043c\u0435 \u0444\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u0438 \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439. \u0422\u0440\u0430\u043d\u0441\u043b\u044f\u0446\u0438\u043e\u043d\u043d\u0430\u044f \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0430. 2014; 2: 5\u201312. ISSN 2311-4495)."},{"key":"ref7","unstructured":"Yavelov I. S. Main indications for peroral anticoagulants: how to choose an optimal drug. High-quality clinical practice. 2017; 3: 53\u201360. ISSN 2588-0519. Russian. (\u042f\u0432\u0435\u043b\u043e\u0432 \u0418. \u0421. \u041e\u0441\u043d\u043e\u0432\u043d\u044b\u0435 \u043f\u043e\u043a\u0430\u0437\u0430\u043d\u0438\u044f \u043a \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044e \u043f\u0435\u0440\u043e\u0440\u0430\u043b\u044c\u043d\u044b\u0445 \u0430\u043d\u0442\u0438\u043a\u043e\u0430\u0433\u0443\u043b\u044f\u043d\u0442\u043e\u0432: \u043a\u0430\u043a \u0432\u044b\u0431\u0440\u0430\u0442\u044c \u043e\u043f\u0442\u0438\u043c\u0430\u043b\u044c\u043d\u044b\u0439 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442. \u041a\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u0430\u044f \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430. 2017; 3: 53\u201360. ISSN 2588-0519.)."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007; 146 (12): 857\u2013867. PMID: 17577005. DOI: 10.7326\/0003-4819-146-12-200706190-00007.","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"ref9","unstructured":"Shubik Y. V. Antithrombotic therapy of atrial fibrillation. New oral anticoagulants. Medical council. 2014; 11: 38\u201348. ISSN 2658-5790. Russian. (\u0428\u0443\u0431\u0438\u043a \u042e. \u0412. \u0410\u043d\u0442\u0438\u0442\u0440\u043e\u043c\u0431\u043e\u0442\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0442\u0435\u0440\u0430\u043f\u0438\u044f \u043f\u0440\u0438 \u0444\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u0438 \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439. \u041d\u043e\u0432\u044b\u0435 \u043f\u0435\u0440\u043e\u0440\u0430\u043b\u044c\u043d\u044b\u0435 \u0430\u043d\u0442\u0438\u043a\u043e\u0430\u0433\u0443\u043b\u044f\u043d\u0442\u044b. \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0441\u043e\u0432\u0435\u0442. 2014; 11: 38\u201348. ISSN 2658-5790)."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Connolly S. J., Ezekowitz M. D., Yusuf S., Eikelboom J., Oldgren J., Parekh A. et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2009; 361 (12): 1139\u20131151. DOI: 10.1056\/NEJMoa0905561.","DOI":"10.1056\/NEJMoa0905561"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Patel M. R., Mahaffey K. W., Garg J., Pan G., Singer D. E., Hacke W. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365 (10): 883\u2013891. DOI: 10.1056\/NEJMoa1009638.","DOI":"10.1056\/NEJMoa1009638"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Granger C. B., Alexander J. H., McMurray J. J., Lopes R. D., Hylek E. M., Hanna M. et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365 (11): 981\u2013992. DOI: 10.1056\/NEJMoa1107039.","DOI":"10.1056\/NEJMoa1107039"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Giugliano R. P., Ruff C. T., Braunwald E., Murphy S. A., Wiviott S. D., Halperin J. L. et al. Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2013; 369: 2093\u20132104. DOI: 10.1056\/NEJMoa1310907.","DOI":"10.1056\/NEJMoa1310907"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ruff C. T., Giugliano R. P., Braunwald E., Hoffman E. B., Deenadayalu N., Ezekowitz M. D. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014; 383 (9921): 955\u2013962. DOI: 10.1016\/S0140-6736(13)62343-0.","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"ref15","unstructured":"Revishvili A. S., Shlyakhto E. V., Popov S. V., Pokushalov E. A., Shkolnikova M. A., Sulimov V .A. et al. Clinical recommendations about carrying out electrophysiological researches, ablation and use of the implanted antiarrhythmic devices. New edition. 2017. 701 p. ISBN 978-5-9500922-0-6. Russian (\u0420\u0435\u0432\u0438\u0448\u0432\u0438\u043b\u0438 \u0410. \u0428., \u0428\u043b\u044f\u0445\u0442\u043e \u0415. \u0412., \u041f\u043e\u043f\u043e\u0432 \u0421. \u0412., \u041f\u043e\u043a\u0443\u0448\u0430\u043b\u043e\u0432 \u0415. \u0410., \u0428\u043a\u043e\u043b\u044c\u043d\u0438\u043a\u043e\u0432\u0430 \u041c. \u0410., \u0421\u0443\u043b\u0438\u043c\u043e\u0432 \u0412. \u0410. \u0438 \u0434\u0440. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u043f\u043e \u043f\u0440\u043e\u0432\u0435\u0434\u0435\u043d\u0438\u044e \u044d\u043b\u0435\u043a\u0442\u0440\u043e\u0444\u0438\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439, \u043a\u0430\u0442\u0435\u0442\u0435\u0440\u043d\u043e\u0439 \u0430\u0431\u043b\u044f\u0446\u0438\u0438 \u0438 \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044e \u0438\u043c\u043f\u043b\u0430\u043d\u0442\u0438\u0440\u0443\u0435\u043c\u044b\u0445 \u0430\u043d\u0442\u0438\u0430\u0440\u0438\u0442\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0443\u0441\u0442\u0440\u043e\u0439\u0441\u0442\u0432. \u041d\u043e\u0432\u0430\u044f \u0440\u0435\u0434\u0430\u043a\u0446\u0438\u044f. 2017. 701 \u0441. ISBN 978-5-9500922-0-6)."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Steffel J., Verhamme P., Potpara T. S., Albaladejo P., Antz M., Desteghe L. et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018; 39 (16): 1330\u20131393. DOI: 10.1093\/eurheartj\/ehy136.","DOI":"10.1093\/eurheartj\/ehy136"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"January C. T., Wann L. S., Calkins H., Chen L.Y., Cigarroa J. E., Cleveland J. C. Jr. et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019; 74 (1): 104\u2013132. DOI: 10.1016\/j.jacc.2019.01.011.","DOI":"10.1016\/j.jacc.2019.01.011"},{"key":"ref18","unstructured":"Novikova N. A., Volovchenko A. N., Oldakovsky V. I. Gastrointestinal complications of anticoagulant therapy in patients with non-valvular atrial fibrillation. Eksperimental'naya i klinicheskaya gastroenterologiya. 2015; 118 (6): 57\u201363. ISSN 1682-8658. Russian. (\u041d\u043e\u0432\u0438\u043a\u043e\u0432\u0430 \u041d. \u0410., \u0412\u043e\u043b\u043e\u0432\u0447\u0435\u043d\u043a\u043e \u0410. \u041d., \u041e\u043b\u0434\u0430\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u0412. \u0418. \u0413\u0430\u0441\u0442\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043e\u0441\u043b\u043e\u0436\u043d\u0435\u043d\u0438\u044f \u0430\u043d\u0442\u0438\u043a\u043e\u0430\u0433\u0443\u043b\u044f\u043d\u0442\u043d\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0441 \u043d\u0435\u043a\u043b\u0430\u043f\u0430\u043d\u043d\u043e\u0439 \u0444\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u0435\u0439 \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439. \u042d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u0430\u044f \u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2015; 118 (6): 57\u201363. ISSN 1682-8658)."},{"key":"ref19","unstructured":"Sulimov V. A., Napalkov D. A., Sokolova A. A., Jilenko A. V., Anikina O. S. Anticoagulant therapy in everyday clinical practice: data of the retrospective cross-sectional study. Ration Pharmacother Cardiol. 2015; 11 (2): 116\u2013123. ISSN 1560-4071. DOI: 10.20996\/1819-6446-2015-11-2-116-123. Russian. (\u0421\u0443\u043b\u0438\u043c\u043e\u0432 \u0412. \u0410., \u041d\u0430\u043f\u0430\u043b\u043a\u043e\u0432 \u0414. \u0410., \u0421\u043e\u043a\u043e\u043b\u043e\u0432\u0430 \u0410. \u0410., \u0416\u0438\u043b\u0435\u043d\u043a\u043e \u0410. \u0412., \u0410\u043d\u0438\u043a\u0438\u043d\u0430 \u041e. \u0421. \u0410\u043d\u0442\u0438\u043a\u043e\u0430\u0433\u0443\u043b\u044f\u043d\u0442\u043d\u0430\u044f \u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0432 \u0440\u0435\u0430\u043b\u044c\u043d\u043e\u0439 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0435: \u0434\u0430\u043d\u043d\u044b\u0435 \u0440\u0435\u0442\u0440\u043e\u0441\u043f\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0433\u043e \u043e\u0434\u043d\u043e\u043c\u043e\u043c\u0435\u043d\u0442\u043d\u043e\u0433\u043e \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f. \u0420\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u0430\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0432 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438. 2015; 11 (2): 116\u2013123. ISSN 1560-4071. DOI: 10.20996\/1819-6446-2015-11-2-116-123)."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Atakanova A. N., Kadyraliev J. K., Erlich A. D. Analysis of the frequency of using various anticoagulants in patients with atrial fibrillation in real practice. Eurasian heart journal. 2017; 4 (11): 112\u2013113. ISSN 2225-1685. Russian. (\u0410\u0442\u0430\u043a\u0430\u043d\u043e\u0432\u0430 \u0410. \u041d., \u041a\u0430\u0434\u044b\u0440\u0430\u043b\u0438\u0435\u0432 \u0416. \u041a., \u042d\u0440\u043b\u0438\u0445 \u0410. \u0414. \u0410\u043d\u0430\u043b\u0438\u0437 \u0447\u0430\u0441\u0442\u043e\u0442\u044b \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043d\u0438\u044f \u0440\u0430\u0437\u043b\u0438\u0447\u043d\u044b\u0445 \u0430\u043d\u0442\u0438\u043a\u043e\u0430\u0433\u0443\u043b\u044f\u043d\u0442\u043e\u0432 \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0444\u0438\u0431\u0440\u0438\u043b\u043b\u044f\u0446\u0438\u0435\u0439 \u043f\u0440\u0435\u0434\u0441\u0435\u0440\u0434\u0438\u0439 \u0432 \u0440\u0435\u0430\u043b\u044c\u043d\u043e\u0439 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0435. \u0415\u0432\u0440\u0430\u0437\u0438\u0439\u0441\u043a\u0438\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b. 2017; 4 (11): 110\u2013111. ISSN 2225-1685).","DOI":"10.38109\/2225-1685-2017-4-110-113"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Potpara T. S., Ferro C. J., Lip G. Y. H. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. Nat Rev Nephrol. 2018; 14 (5): 337\u2013351. DOI: 10.1038\/nrneph.2018.19.","DOI":"10.1038\/nrneph.2018.19"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Heidbuchel H., Verhamme P., Alings M., Antz M., Diener H. C., Hacke W. et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015; 17 (10): 1467\u20131507. DOI: 10.1093\/europace\/euv309.","DOI":"10.1093\/europace\/euv309"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Bansal N., Fan D., Hsu C. Y., Ordonez J. D., Marcus G. M., Go A. S. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013; 127 (5): 569\u2013574. DOI: 10.1161\/CIRCULATIONAHA.112.123992.","DOI":"10.1161\/CIRCULATIONAHA.112.123992"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Bansal N., Xie D., Tao K., Chen J., Deo R., Horwitz E. et al. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clin J Am Soc Nephrol. 2016; 11 (7): 1189\u20131196. DOI: 10.2215\/CJN.10921015.","DOI":"10.2215\/CJN.10921015"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"B\u00f6hm M., Ezekowitz M.D., Connolly S.J., Eikelboom J.W., Hohnloser S.H., Reilly P.A. et al. Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial. J Am Coll Cardiol. 2015 Jun 16;65(23):2481-93. DOI: 10.1016\/j.jacc.2015.03.577","DOI":"10.1016\/j.jacc.2015.03.577"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"van Gorp R. H., Schurgers L. J. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs). Nutrients. 2015; 7 (11): 9538\u20139557. DOI: 10.3390\/nu7115479.","DOI":"10.3390\/nu7115479"},{"key":"ref27","unstructured":"Petkova N. Y., Petrova K. B., Bliznakova M. I., Paskalev D. N., Galunska B. T. The new face of vitamin K\u2009\u2014\u2009more than blood clotting factor. Nephrology. 2018; 22 (1): 29\u201337. DOI: 10.24884\/1561-6274-2018-22-1-29-37. (\u041f\u0435\u0442\u043a\u043e\u0432\u0430 \u041d. \u0418., \u041f\u0435\u0442\u0440\u043e\u0432\u0430 \u041a. \u0411., \u0411\u043b\u0438\u0437\u043d\u0430\u043a\u043e\u0432\u0430 \u041c. \u0418., \u041f\u0430\u0441\u043a\u0430\u043b\u0435\u0432 \u0414. \u041d., \u0413\u0430\u043b\u0443\u043d\u0441\u043a\u0430 \u0411. \u0422. \u041d\u043e\u0432\u044b\u0439 \u043e\u0431\u0440\u0430\u0437 \u0432\u0438\u0442\u0430\u043c\u0438\u043d\u0430 \u041a\u2009\u2014\u2009\u0431\u043e\u043b\u044c\u0448\u0435, \u0447\u0435\u043c \u0444\u0430\u043a\u0442\u043e\u0440 \u0441\u0432\u0435\u0440\u0442\u044b\u0432\u0430\u043d\u0438\u044f \u043a\u0440\u043e\u0432\u0438. \u041d\u0435\u0444\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2018; 22 (1): 29\u201337. DOI: 10.24884\/1561-6274-2018-22-1-29-37)."}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/1023\/664","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:42Z","timestamp":1793639802000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/1023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,5,4]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2020.4.n1023","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,4]]}}}